Florence Thomas

1.6k citations

26 papers · 1.2k indexed · h-index 19

Impact in

Pharmacology top 5%
- Pharmacology and Obesity Treatment
Epidemiology top 5%
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies

Papers in ⓘ

Epidemiology 18
- Cervical Cancer and HPV Research 17
- Hepatitis B Virus Studies 16
- Herpesvirus Infections and Treatments 3
Surgery 9
- Genital Health and Disease 8

Co-authors: Corinne Hanotin (4 shared papers)E. Leutenegger (4 shared papers)P Vague (1 shared paper)Olivier Ziegler (1 shared paper)M Apfelbaum (1 shared paper)Dominique Descamps (9 shared papers)Tino F. Schwarz (9 shared papers)P.V. Suryakiran (7 shared papers)
Journals: Human Vaccines & Immunotherapeutics (3 papers)Vaccine (3 papers)Journal of Adolescent Health (2 papers)International Journal of Gynecology & Obstetrics (2 papers)Clinical Neurophysiology (1 paper)
Partner nations: Belgium France Germany

In The Last Decade

Florence Thomas

26 papers receiving 1.1k citations

Peers

Countries citing papers authored by Florence Thomas

Since Specialization

Citations

This map shows the geographic impact of Florence Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Thomas more than expected).

Fields of papers citing papers by Florence Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florence Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Thomas. The network helps show where Florence Thomas may publish in the future.

Co-authors

The 25 scholars most cited alongside Florence Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Florence Thomas Line = papers co-authored together Florence Thomas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine The American Journal of Medicine ·M Apfelbaum, P Vague, Olivier Ziegler, Corinne Hanotin, Florence Thomas, E. Leutenegger	1999	263
2	Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination Human Vaccines & Immunotherapeutics ·Barbara Romanowski, Tino F. Schwarz, Linda M. Ferguson, Murdo Ferguson, Klaus Peters, Marc Dionne, Karin Schulze, Brian Ramjattan, Peter Hillemanns, Ulrich Behre, P.V. Suryakiran, Florence Thomas, Frank Struyf	2014	85
3	Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: A partially-blind randomised placebo-controlled study Vaccine ·Lynette Denny, Bronwyn Hendricks, Chivaugn Gordon, Florence Thomas, Marjan Hezareh, Kurt Dobbelaere, Christelle Durand, Caroline Hervé, Dominique Descamps	2013	79
4	Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study International Journal of Obesity ·Corinne Hanotin, Florence Thomas, S W Jones, E. Leutenegger, Pierre Drouin	1997	78
5	Long‐term persistence of systemic and mucosal immune response to HPV‐16/18 AS04‐adjuvanted vaccine in preteen/adolescent girls and young women International Journal of Cancer ·Tiina Petäjä, Court Pedersen, Airi Põder, Gitte Strauss, Grégory Catteau, Florence Thomas, Matti Lehtinen, Dominique Descamps	2010	73
6	Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study Human Vaccines & Immunotherapeutics ·Barbara Romanowski, Tino F. Schwarz, Linda Ferguson, Klaus Peters, Marc Dionne, Ulrich Behre, Karin Schulze, Peter Hillemanns, P.V. Suryakiran, Florence Thomas, Frank Struyf	2015	70
7	Ten‐year immune persistence and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in females vaccinated at 15–55 years of age Cancer Medicine ·Tino F. Schwarz, Andrzej Gałaj, Marek Spaczyński, Jacek Wysocki, Andreas M. Kaufmann, Sylviane Poncelet, P.V. Suryakiran, Nicolas Folschweiller, Florence Thomas, Lan Lin, Frank Struyf	2017	58
8	Safety and Immunogenicity of Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine: A Randomized Trial in 10–25-Year-Old HIV-Seronegative African Girls and Young Women The Journal of Infectious Diseases ·Papa Salif Sow, Deborah Watson‐Jones, Nancy B. Kiviat, John Changalucha, Khardiata Diallo Mbaye, Joelle Brown, Kouro Bousso, Bazil Baltazar Kavishe, Aura Andreasen, Macoumba Touré, Saidi Kapiga, Philippe Mayaud, Richard Hayes, Marie Lebacq, Marjan Herazeh, Florence Thomas, Dominique Descamps	2012	52
9	Four-Year Follow-up of the Immunogenicity and Safety of the HPV-16/18 AS04-Adjuvanted Vaccine When Administered to Adolescent Girls Aged 10–14 Years Journal of Adolescent Health ·Tino F. Schwarz, Li‐Min Huang, Doris Maribel Rivera Medina, Alejandra Valencia, Tzou‐Yien Lin, Ulrich Behre, Grégory Catteau, Florence Thomas, Dominique Descamps	2012	49
10	Nifurtimox plus Eflornithine for Late-Stage Sleeping Sickness in Uganda: A Case Series PLoS neglected tropical diseases ·Francesco Checchi, Patrice Piola, Harriet Ayikoru, Florence Thomas, Dominique Legros, Gérardo Priotto	2007	47
11	Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9–14 years: Results to month 12 from a randomized trial Human Vaccines & Immunotherapeutics ·Ting Fan Leung, Anthony Pak‐Yin Liu, Fong Seng Lim, Franck Thollot, Helen May Lin Oh, Bee Wah Lee, Lars Rombo, Ngiap Chuan Tan, Roman Rouzier, Damien Friel, Benoit De Muynck, Stéphanie De Simoni, P.V. Suryakiran, Marjan Hezareh, Nicolas Folschweiller, Florence Thomas, Frank Struyf	2015	41
12	Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 years Human Vaccines ·Tino F. Schwarz, Marek Spaczyński, Achim Schneider, Jacek Wysocki, Andrzej Gałaj, Karin Schulze, Sylviane Poncelet, Grégory Catteau, Florence Thomas, Dominique Descamps	2011	33
13	Modalities of the food intake-reducing effect of sibutramine in humans Physiology & Behavior ·Didier Chapelot, Corinne Marmonier, Florence Thomas, Corinne Hanotin	2000	32
14	A Comparison of Sibutramine and Dexfenfluramine in the Treatment of Obesity Obesity Research ·Corinne Hanotin, Florence Thomas, Stephen P. Jones, E. Leutenegger, Pierre Drouin	1998	32
15	Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-Adjuvanted Cervical Cancer Vaccine Coadministered With Combined Diphtheria-Tetanus-Acellular Pertussis–inactivated Poliovirus Vaccine to Girls and Young Women Journal of Adolescent Health ·José García-Sicilia, Tino F. Schwarz, Alfonso Carmona, Klaus Peters, Jean‐Elie Malkin, Phu My Tran, Ulrich Behre, E. Bernaola Iturbe, Grégory Catteau, Florence Thomas, Kurt Dobbelaere, Dominique Descamps, Gary Dubin	2010	31
16	Antibody avidity measurements in recipients of Cervarix® vaccine following a two-dose schedule or a three-dose schedule Vaccine ·Mathieu Boxus, Laurence Lockman, Michel Fochesato, Clarisse Lorin, Florence Thomas, Sandra L. Giannini	2014	31
17	Persistence of immune responses to the HPV‐16/18 AS04‐adjuvanted vaccine in women aged 15–55 years and first‐time modelling of antibody responses in mature women: results from an open‐label 6–year follow‐up study BJOG An International Journal of Obstetrics & Gynaecology ·Tino F. Schwarz, Marek Spaczyński, Andreas M. Kaufmann, Jacek Wysocki, Andrzej Gałaj, Karin Schulze, P.V. Suryakiran, Florence Thomas, Dominique Descamps	2014	29
18	Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine Administered According to an Alternative Dosing Schedule Compared With the Standard Dosing Schedule in Healthy Women Aged 15 to 25 Years The Pediatric Infectious Disease Journal ·Susanna Esposito, Victoria Bîrluțiu, Pavol Jarčuška, A Perino, Sorin Claudiu Man, Radu Vlădăreanu, Dorothée Meric, Kurt Dobbelaere, Florence Thomas, Dominique Descamps	2011	28
19	Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9–14 years: Results to month 36 from a randomized trial Vaccine ·Ting Fan Leung, Anthony Pak‐Yin Liu, Fong Seng Lim, Franck Thollot, Helen May Lin Oh, Bee Wah Lee, Lars Rombo, Ngiap Chuan Tan, Roman Rouzier, Stéphanie De Simoni, P.V. Suryakiran, Marjan Hezareh, Florence Thomas, Nicolas Folschweiller, Frank Struyf	2017	22
20	[Ibuprofen 800 mg in the treatment of arthrosis of the fingers or rhizarthrosis]. PubMed ·R.-L. Dreiser, Marta Gersberg, Florence Thomas, S. Courcier	1993	15

About Florence Thomas

Florence Thomas is a scholar working on Epidemiology, Surgery, Pharmacology, Clinical Psychology and Immunology, having authored 26 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (17 papers), Hepatitis B Virus Studies (16 papers), Genital Health and Disease (8 papers), Eating Disorders and Behaviors (4 papers), Pharmacology and Obesity Treatment (4 papers), Immunotherapy and Immune Responses (3 papers), Herpesvirus Infections and Treatments (3 papers) and Diet and metabolism studies (2 papers). The work is most often cited by research in Pharmacology (348 citations), Epidemiology (677 citations), Endocrine and Autonomic Systems (75 citations), Endocrinology, Diabetes and Metabolism (165 citations) and Microbiology (57 citations). Florence Thomas has collaborated with scholars based in Belgium, France and Germany. Frequent co-authors include Corinne Hanotin, E. Leutenegger, P Vague, Olivier Ziegler, M Apfelbaum, Dominique Descamps, Tino F. Schwarz, P.V. Suryakiran, Frank Struyf and Pierre Drouin. Their work appears in journals such as Human Vaccines & Immunotherapeutics, Vaccine, Journal of Adolescent Health, International Journal of Gynecology & Obstetrics and Clinical Neurophysiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact